EPISODE · Jan 19, 2022 · 47 MIN
55. The Right to Try with Spencer Hawkswell
from The Drug Science Podcast · host Drug Science
If you were told you had months, weeks or even days left to live...would you care what the law said about consuming psychoactive substances? This week’s episode features Spencer Hawkswell the CEO of TheraPsil - a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress. Spencer believes that responsible drug policy requires effective organization and leadership and is dedicated to bringing together the experts and advocates, to facilitate change that results in increased access to compassionate care, harm reduction, and treatment options for those in need.Tune in to this week’s episode to hear how the Land of Maple Leaf implements its patient-centred approach in healthcare. What happened in the UK? Are there lessons to be learnt from Canada? PsilocybinCannabisTrigeminal neuralgia Patty HajduJean-Yves DuclosHealth CanadaFentanyl Clonazepam Section 56 Exemption Roland R. GriffithsMathew W. JohnsonRobin Carhart-HarrisAnthony P. BossisKetamineHolotropic breathworkCluster headacheADHDAcid (LSD)Medical assistance in dyingLetter to Minister DuclosRe: Proposed Regulations for Medical Access to Psilocybin ★ Support this podcast ★
Embed this episode
What this episode covers
Being diagnosed with a terminal disease can provoke extreme psychological distress, depression and anxiety. Current pharmacological treatments take a long time to exert an effect, if any. Psychedelics offer a new, fast-acting treatment for palliative patients.
Ready to play
55. The Right to Try with Spencer Hawkswell
No transcript for this episode yet
Similar Episodes
No similar episodes found.